EDX/20/1154
Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
EDX/20/1154
Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
NICE has published new rapid guidelines on the active management of patients with suspected and confirmed COVID-19, and in patients without COVID-19. The guidelines have been designed to maximise the safety of patients whilst enabling services to make the best use of NHS resources.
The guideline on severe asthma says that people should continue to take their treatment as prescribed and only attend essential appointments alone, if possible, to minimize the risk of infection.
The guideline recommends that patients should be advised to regularly clean equipment such as face masks and mouthpieces and that they should not share their inhalers and devices with anyone else.
Click here to access the COVID-19 rapid guideline on severe asthma
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.
This site is for healthcare professionals, please confirm you are a healthcare professional to continue.
Begin the discussion right here